William Johnson, Anjali Mishra, Adam Binder, Alejandro Gru, Pierluigi Porcu. Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?. haematol [Internet]. 2019Apr.30 [cited 2024Dec.1];104(5):864-7. Available from: https://haematologica.org/article/view/8888